Osteomyelitis

• CLINICAL_TRIALS withdrawal · 2025-06-15
  Clinical Trial Update: Performances of DendrisCHIP®OA in Bone and Joint Infections

  A clinical trial evaluating the DendrisCHIP OA diagnostic for bone and joint infections has been withdrawn. The study status on ClinicalTria…

• EMA withdrawal · 2018-02-09
  EMA Withdrawn: LeukoScan (sulesomab) — Immunomedics GmbH

  EMA withdrawn LeukoScan (sulesomab) from Immunomedics GmbH; previously indicated for osteomyelitis and radionuclide imaging.

• CLINICAL_TRIALS withdrawal · 2016-09-23
  Clinical Trial Update: Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis [Phase 3]

  A Phase 3 pediatric trial comparing dalbavancin to a comparator for acute hematogenous osteomyelitis has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2015-02-06
  Clinical Trial Update: Diagnostic Tests to Help Determine Osteomyelitis

  Georgetown University’s clinical trial evaluating diagnostic tests for determining osteomyelitis has been terminated.

• CLINICAL_TRIALS withdrawal · 2014-08-07
  Clinical Trial Update: Ceftaroline in the Treatment of Bone and Joint Infections [Phase 4]

  Phase 4 clinical trial evaluating ceftaroline fosamil for bone and joint infections has been withdrawn.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS withdrawal · 2012-09-17
  Clinical Trial Update: a Randomized Controlled Trial Comparing Medical and Medical-surgical Treatment in Diabetic Foot Osteomyelitis [Phase 4]

  A Phase 4 randomized trial comparing medical versus medical-surgical treatment for diabetic foot osteomyelitis has been withdrawn.